These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27881356)

  • 1. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
    Yang SM; Shi YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
    Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
    DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
    J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
    Cui J; Shen L; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
    Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
    Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
    Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
    Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
    Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
    Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
    Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.